DTB Select: DOAC dose adjustment in renal impairment

Commentary and context are provided for a US registry-based study (n=6,682) which found that of the 4% of people treated with a DOAC who met the criteria for a dose reduction, only 20% of them had an appropriate dose adjustment.


Drug and Therapeutics Bulletin